stockrowIngevity Corporation
NGVT Basic Materials Specialty Chemicals
Ingevity Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, down 2.71% from fiscal 2024.
- Revenue
- −5.25%
- EPS
- +125.4%
- Free cash flow
- −136.1%
- Total debt
- −14.5%
Quarter to June 2026, against a year earlier
Follow NGVT
Alert me
Ingevity Corporation (NGVT) Total debt
Ingevity Corporation's total debt at the end of fiscal 2025 was $1.2B, down 13.3% from $1.3B in fiscal 2024. At the end of the quarter to 30 June 2026 it was $1.1B. Over the past ten years it has ranged from $80.0M (fiscal 2015) to $1.5B (fiscal 2022); the current reading is higher than 45% of that period. Ingevity Corporation ranks 25th of 60 Specialty Chemicals companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2025 | $1.2B | (13.31%) |
| FY2024 | $1.3B | (3.12%) |
| FY2023 | $1.4B | (6.09%) |
| FY2022 | $1.5B | 17.80% |
| FY2021 | $1.3B | (1.37%) |
| FY2020 | $1.3B | 3.17% |
| FY2019 | $1.2B | 65.73% |
| FY2018 | $741.2M | 63.48% |
| FY2017 | $453.4M | (7.24%) |
| FY2016 | $488.8M | 511.00% |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Jun 2026 | $1.1B | (2.42%) |
| Mar 2026 | $1.1B | (6.80%) |
| Dec 2025 | $1.2B | 0.25% |
| Sep 2025 | $1.2B | (6.24%) |
| 39 more quarters | Free account |
Against its own ten years
Total debt against peers
| Company | Total debt |
|---|---|
| CC The Chemours Company compare | $3.8B |
| FUL H. B. Fuller Company compare | $2.1B |
| NGVT Ingevity Corporation | $1.1B |
| MTX Minerals Technologies Inc. compare | $957.8M |
| KWR Quaker Houghton compare | $892.0M |
| HWKN Hawkins, Inc. compare | $229.0M |
| WDFC WD-40 Company compare | $86.0M |
| IOSP Innospec Inc. compare | $42.0M |
| STDN Standard Nuclear Inc compare | — |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on NGVT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement